Take this letter to your doctor to order one of Invitae's proactive tests.Download
Invitae has found that over 16% of healthy adults carry a serious health-related genetic risk.1
Invitae offers three test options so you can select the type of information you want to receive.
Invitae cancer screenAnalyzes 61 genes
Invitae cardio screenAnalyzes 77 genes
Invitae genetic health screenAnalyzes 147 genes
|Renal cell cancer|
|Genetic forms of high blood
pressure and high cholesterol
|Alpha-1 antitrypsin deficiency|
*Invitae does not support insurance billing for proactive testing.
Due to the potential health implications of this test, Invitae proactive tests must be ordered by a doctor. Print this letter and take it to your doctor to request an Invitae proactive test.
Either provide a blood sample in your clinician’s office or a saliva sample at home.
Once the laboratory receives your sample, your DNA will be tested and your doctor will receive your results in 10 to 21 days.
Based on your results, you can work with your doctor to develop a proactive—and personalized—plan focused on prevention.
You can also speak with Invitae’s genetic counselors about your results.*
*Offered in the US and Canada only. In other countries, your doctor can consult with an Invitae genetic counselor.
If you receive a positive test result, this means that your test found a clinically significant genetic change that increases your risk of developing a specific medical condition. This does not mean that you will definitely develop that condition, but it does mean that you are significantly more likely to develop it than the average person.
The Invitae proactive tests may also indicate if you carry a genetic change that does not increase your own risk of developing a specific medical condition, but that may be passed within your family. This is known as carrier status. Carriers typically do not have symptoms or a family history of the disorder.
If you receive a negative test result, this means that you do not carry genetic changes in the genes evaluated that are currently known to be associated with serious health conditions.